Cargando…

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation

Detalles Bibliográficos
Autores principales:	Collotta, Debora, Lucarini, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351978/ https://www.ncbi.nlm.nih.gov/pubmed/37465521 http://dx.doi.org/10.3389/fphar.2023.1242880

Ejemplares similares

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Editorial: Translational Research and Drug Repurposing for Non-Communicable Diseases (NCDs)
por: Akindele, Abidemi J., et al.
Publicado: (2022)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023)

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022)

Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
por: Jin, Ming-Zhu, et al.
Publicado: (2023)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
por: Sultana, Janet, et al.
Publicado: (2020)

The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience
por: Gozzo, Lucia, et al.
Publicado: (2020)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
por: Li, Xinlei, et al.
Publicado: (2021)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
por: Ma, Zhaowu, et al.
Publicado: (2021)

Editorial: Autophagy in Inflammation Related Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements
por: Frega, Giorgio, et al.
Publicado: (2020)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Editorial: Enteric inflammation and chronic diseases: Is there a link?
por: Marzocco, Stefania, et al.
Publicado: (2022)

Drug Repurposing for Rare Diseases: A Role for Academia
por: van den Berg, Sibren, et al.
Publicado: (2021)

The hidden role of NLRP3 inflammasome in obesity‐related COVID‐19 exacerbations: Lessons for drug repurposing
por: Bertocchi, Ilaria, et al.
Publicado: (2020)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs
por: Peluso, Ilaria, et al.
Publicado: (2020)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Enrichment analysis of phenotypic data for drug repurposing in rare diseases
por: Ambesi-Impiombato, Alberto, et al.
Publicado: (2023)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases
por: Li, Xiaohui, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Editorial: The Role of Natural Products in Chronic Inflammation
por: Deng, Wenjun, et al.
Publicado: (2022)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs, Volume II
por: Peluso, Ilaria, et al.
Publicado: (2022)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)

Screening of GPCR drugs for repurposing in breast cancer
por: Abdulkareem, Noor Mazin, et al.
Publicado: (2022)

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020)

Editorial: Inflammation and aging in chronic and degenerative diseases: Current and future therapeutic strategies
por: Falzone, Luca, et al.
Publicado: (2023)

Recent advances in JAK inhibitors for the treatment of metabolic syndrome
por: Collotta, Debora, et al.
Publicado: (2023)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
por: Pantziarka, Pan, et al.
Publicado: (2018)

Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study
por: Gesualdo, Carlo, et al.
Publicado: (2021)

A Database of Drug Repurposing Clinical Trials in Oncology
por: Pantziarka, Pan, et al.
Publicado: (2021)

Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
por: Shah, Sweta, et al.
Publicado: (2021)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Editorial: Dietary Supplements, Botanicals and Herbs at the Interface of Food and Medicine
por: Durazzo, Alessandra, et al.
Publicado: (2022)

Editorial: Environmental Enrichment as a Treatment? Epigenetic Mechanisms, Challenges and Limitations
por: Redolat, Rosa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jvb4fvhvgkp04gg1jn4c22kaao